1.Sumoylation and its role in hematological disease.
Journal of Experimental Hematology 2013;21(1):218-221
Small ubiquitin-related modifier (SUMO) can be covalently attached to target proteins and thereby plays a crucial role in regulating the normal functions of cells, such as protein-protein interaction, subcellular localization, DNA repair, cell cycle and transcription factor regulation. Several lines have implicated that sumoylation is important in disease occurrence and development. This brief review will focus on some recent findings about the roles of sumoylation in the etiology and treatment of hematological malignancies.
Animals
;
Hematologic Diseases
;
pathology
;
therapy
;
Humans
;
Sumoylation
4.Spontaneous Splenic Rupture Secondary to a Metastatic Gastric Carcinoma.
Jun Young RHO ; Seok Young RYU ; Suk Jin CHO ; Sang Lae LEE ; Hong Yong KIM
Journal of the Korean Society of Emergency Medicine 2005;16(1):218-220
Pathologic splenic rupture is an uncommon finding associated with a long list of pathologic conditions, including infectious diseases, hematologic diseases, metabolic disorders, drug therapy, primary and secondary benign or malignant splenic tumors, acute or chronic pancreatitis, collagen disorders pregnancy, and others. In this report, we present a case study of a pathologic splenic rupture caused by metastasis from a previously undiagnosed gastric carcinoma.
Collagen
;
Communicable Diseases
;
Drug Therapy
;
Hematologic Diseases
;
Neoplasm Metastasis
;
Pancreatitis, Chronic
;
Pregnancy
;
Splenic Rupture*
5.CRISPR/Cas9 System and Its Advances in Gene Therapy of Hematologic Diseases--Review.
Wan-Ying LI ; Qing-Ping GAO ; Hui LIU
Journal of Experimental Hematology 2018;26(6):1863-1867
In recent years, with the development of gene editing technology, the site-specific genome can be modified. The curability of genetic disease may be achieved by the use of gene editing techniques. As the simplicity, high specificity and economical efficiency, much attention has been paid to the CRISPR/Cas9 system, which was been widely used in research of molecular biology and other fields of life science. In this review, the mechanism for CR1SPR/Cas9 system and the progress of gene therapy, such as for hemophilia, betathalassaemia and chronic myeloid leukemia were summarized briefly.
CRISPR-Cas Systems
;
Gene Editing
;
Genetic Therapy
;
Hematologic Diseases
;
therapy
;
Humans
;
Molecular Biology
7.Effects of Siwu tang on serum protein of blood deficiency using proteomic technique.
Ming-Hui YANG ; Zeng-Chun MA ; Yong-Qi DOU ; Jian HU ; Yu-Guang WANG ; Hong-Ling TAN ; Cheng-Rong XIAO ; Yue GAO
China Journal of Chinese Materia Medica 2008;33(4):420-423
OBJECTIVETo research the effects of Siwu tang on serum protein of blood deficiency using proteomic technique and further explore its potential molecular mechanism to cure blood deficiency.
METHODThe sera of normal, blood deficiency and cured group were collected. Proteomic protocol involving the high resolution two-dimensional polyacryamide gel electrophoresis, the computer-assisted image analysis, and the mass spectrometry was used to detect regulated protein by Siwu tang.
RESULTCompared with normal group, there were 15 proteins changed, in which 11 increased and 4 decreased expressed proteins in sera could be recovered by Siwu tang. The up-regulated proteins involved haptoglobin, clusterin, complement component C4B and GTP binding protein 2, while the down-regulated proteins involved transthyretin and heamoglobin beta.
CONCLUSIONSiwu tang could regulate serum protein, which include immunology, apoptosis, DNA injury repair, and blood ingredients. This might be the mechanism of Siwu tang to cure blood deficiency.
Blood Proteins ; drug effects ; Drugs, Chinese Herbal ; pharmacology ; Hematologic Diseases ; blood ; drug therapy ; Humans ; Proteomics ; methods
10.Evaluation of Platelet count by the CELL-DYN Sapphire CD61 Immunoplatelet Method in Patients with Hematologic Diseases Receiving Chemotherapy.
Bo Ram KIM ; Jae Lim CHOI ; Ji Eun KIM ; Kwang Sook WOO ; Kyeoung Hee KIM ; Jeong Man KIM ; Sung Hyun KIM ; Jin Yeong HAN
Laboratory Medicine Online 2015;5(3):133-136
BACKGROUND: The automated hematologic analyzer has increased the precision and accuracy for platelet counting. However, spurious elevations of automated platelet counts occur occasionally in patients receiving chemotherapy or radiotherapy for solid organ tumors, leukemia, and other lymphomas. The CELL-DYN Sapphire analyzer (Abbott, USA) detects platelets with a CD61 monoclonal antibody and uses both impedance and optical technologies; thus, it is expected to present more accurate platelet counts. METHODS: We evaluated platelet counts obtained with the CELL-DYN Sapphire impedance, optical, and CD61 methods and compared them with the results obtained with the XE-2100 analyzer (Sysmex, Japan). We analyzed 111 samples from hospitalized patients with various hematologic diseases, who were receiving chemotherapy or radiotherapy. RESULTS: The results from the impedance, optical, and CD61 methods of CELL-DYN Sapphire and those from XE-2100 showed significant linearity, with correlation coefficients greater than 0.99. Three cases had significantly different platelet counts among the different methods used. Microscopic examination of these three cases showed very low platelet counts that corresponded with the low counts from the CD61 methods. It should be noted that because the automated blood counter assesses cell populations by their dimensions, many cellular fragments that were of the same size or smaller than platelets were thus counted as platelets. CONCLUSIONS: The CELL-DYN Sapphire analyzer has good precision, linearity and performance, comparable with the XE-2100 analyzer. As the CD61 methods of CELL-DYN Sapphire is specific for platelet, this method may reduce the interference from other blood components and count the exact platelet numbers.
Aluminum Oxide*
;
Blood Platelets
;
Drug Therapy*
;
Electric Impedance
;
Hematologic Diseases*
;
Humans
;
Leukemia
;
Lymphoma
;
Platelet Count*
;
Radiotherapy